{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:12:46Z","timestamp":1791562366776,"version":"4.3.4"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T00:00:00Z","timestamp":1705449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Some studies have investigated the impact of intermittent fasting (IF) for patients with multiple sclerosis (MS). We aimed to conduct a comprehensive systematic review to analyze and summarize all clinical studies concerning the effects of IF on patients with MS. We conducted an exhaustive review of information available in the Embase, Cochrane, and PubMed databases up until 1 September 2023. All clinical research relating to the impacts of IF for patients with MS were included. In total, this systematic review encompassed 5 studies, which included four RCTs and one pilot study. Each study involved was assessed of high quality. The results from these studies demonstrate that IF protocols could potentially serve as an effective dietary strategy for managing symptoms and improving the quality of life in individuals afflicted with MS. In conclusion, IF might be a potential beneficial dietary intervention for MS. However, the number of trials in this field is relatively limited. The large-scale clinical trials to investigate the effects of IF for MS are urgently needed, which may be helpful to manage this intricate neuroimmune disorder.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/inplasy.com<\/jats:ext-link>\n                      , identifier INPLASY2023100021.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2023.1328426","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T23:17:55Z","timestamp":1705447075000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review"],"prefix":"10.3389","volume":"10","author":[{"given":"Xiaoxiao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","article-title":"Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.","volume":"19","author":"Benedict","year":"2020","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity.","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102512","article-title":"Clinical outcome measures in multiple sclerosis: A review.","volume":"19","author":"Inojosa","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis.","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat Rev Neurol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework.","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"key":"B6","article-title":"What Is Multiple Sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC202106150","article-title":"Multiple Sclerosis.","volume":"174","author":"Olek","year":"2021","journal-title":"Ann Intern Med."},{"key":"B8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMoa2201904","article-title":"Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.","volume":"387","author":"Steinman","year":"2022","journal-title":"N Engl J Med."},{"key":"B9","article-title":"Multiple sclerosis under the spotlight.","volume":"20","author":"The Lancet","year":"2021","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-673601473-3","article-title":"Multiple sclerosis.","author":"Jakimovski","year":"2023","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science."},{"key":"B13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis.","volume":"619","year":"2023","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(22)00045-X","article-title":"Exercise training in multiple sclerosis.","volume":"21","author":"Sandroff","year":"2022","journal-title":"Lancet Neurol."},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001102","article-title":"Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis.","volume":"9","author":"Bock","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/13524585231190342","article-title":"May Mediterranean diet contribute to reduce risk of multiple sclerosis?","volume":"29","author":"Cavalla","year":"2023","journal-title":"Multiple Scleros."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235003","article-title":"The role of ketogenic diet in the treatment of neurological diseases.","volume":"14","author":"Dy\u0144ka","year":"2022","journal-title":"Nutrients."},{"key":"B18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/1028415X.2022.2034241","article-title":"Is Mediterranean diet associated with multiple sclerosis related symptoms and fatigue severity?","volume":"26","author":"Erta\u015f \u00d6zt\u00fck","year":"2023","journal-title":"Nutr Neurosci."},{"key":"B19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/1028415X.2017.1303016","article-title":"The role of diet in multiple sclerosis: A review.","volume":"21","author":"Esposito","year":"2018","journal-title":"Nutr Neurosci."},{"key":"B20","article-title":"Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis.","volume":"47","author":"Esposito","year":"2021","journal-title":"Multiple Scleros Relat Disord."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu15184009","article-title":"Adherence to mediterranean diet is associated with multiple sclerosis severity.","volume":"15","author":"Guglielmetti","year":"2023","journal-title":"Nutrients."},{"key":"B22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s13668-018-0236-z","article-title":"The role of diet in multiple sclerosis: mechanistic connections and current evidence.","volume":"7","author":"Katz Sand","year":"2018","journal-title":"Curr Nutr Rep."},{"key":"B23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/13524585221127414","article-title":"Mediterranean diet is linked to less objective disability in multiple sclerosis.","volume":"29","author":"Katz Sand","year":"2023","journal-title":"Multiple Scleros."},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1177\/1759091414568185","article-title":"Nutrition facts in multiple sclerosis.","volume":"7","author":"Riccio","year":"2015","journal-title":"ASN Neuro."},{"key":"B25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13311-017-0581-4","article-title":"Diet Gut Microbiota, and Vitamins D + A in Multiple Sclerosis.","volume":"15","author":"Riccio","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jns.2017.04.017","article-title":"Vitamin D supplementation in multiple sclerosis: Symptoms and biomarkers of depression.","volume":"378","author":"Rolf","year":"2017","journal-title":"J Neurol Sci."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061150","article-title":"The Role of Diet and Interventions on Multiple Sclerosis: A Review.","volume":"14","author":"Stoiloudis","year":"2022","journal-title":"Nutrients."},{"key":"B28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.msard.2016.07.001","article-title":"Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.","volume":"9","author":"Yadav","year":"2016","journal-title":"Multiple Scleros Relat Disord."},{"key":"B29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.msard.2018.05.008","article-title":"The efficacy of vitamin D in multiple sclerosis: A meta-analysis.","volume":"23","author":"Zheng","year":"2018","journal-title":"Multiple Scleros Relat Disord."},{"key":"B30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2022-329074","article-title":"Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits.","volume":"93","author":"Brenton","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B31","article-title":"Ketogenic and modified mediterranean diet as a tool to counteract neuroinflammation in multiple sclerosis: nutritional suggestions.","volume":"14","author":"Majo","year":"2022","journal-title":"Nutrients."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo7639","article-title":"Ketogenic diet uncovers differential metabolic plasticity of brain cells.","volume":"8","author":"D\u00fcking","year":"2022","journal-title":"Sci Adv."},{"key":"B33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.14336\/AD.2021.1217","article-title":"Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases.","volume":"13","author":"Jiang","year":"2022","journal-title":"Aging Dis."},{"key":"B34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/07315724.2020.1734988","article-title":"Modified MCT-based ketogenic diet increases plasma \u03b2-hydroxybutyrate but has less effect on fatigue and quality of life in people with multiple sclerosis compared to a modified paleolithic diet: a waitlist-controlled. Randomized Pilot Study.","volume":"40","author":"Lee","year":"2021","journal-title":"J Am Coll Nutr."},{"key":"B35","article-title":"Nutrient composition comparison between the low saturated fat swank diet for multiple sclerosis and healthy U.S.-Style Eating Pattern.","volume":"11","author":"Chenard","year":"2019","journal-title":"Nutrients."},{"key":"B36","article-title":"Association of self-reported adherence to the Mediterranean diet with anthropometric indices, comorbidities, and degree of disability in patients with multiple sclerosis.","volume":"66","author":"Farzinmehr","year":"2022","journal-title":"Multiple Scleros Relat Disord."},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241915024","article-title":"Multiple sclerosis-associated gut microbiome in the israeli diverse populations: associations with ethnicity, gender, disability status, Vitamin D levels, and mediterranean diet.","volume":"24","author":"Nitzan","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/1028415X.2023.2201026","article-title":"The relationship between dietary profile and adherence to the Mediterranean diet with EDSS and quality of life in multiple sclerosis patients: a retrospective cross-sectional study.","author":"Uygun \u00d6zel","year":"2023","journal-title":"Nutr Neurosci."},{"key":"B39","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of Intermittent Fasting on Health, Aging, and Disease.","volume":"381","author":"de Cabo","year":"2019","journal-title":"The New England journal of medicine"},{"key":"B40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamainternmed.2022.3050","article-title":"Effectiveness of early time-restricted eating for weight loss, fat loss, and cardiometabolic health in adults with obesity: a randomized clinical trial.","volume":"182","author":"Jamshed","year":"2022","journal-title":"JAMA Intern Med."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.15140","article-title":"Intermittent Fasting.","volume":"326","author":"Li","year":"2021","journal-title":"JAMA"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.39558","article-title":"Intermittent fasting and obesity-related health outcomes: an umbrella review of meta-analyses of randomized clinical trials.","volume":"4","author":"Patikorn","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B43","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202204487","article-title":"Fasting: from physiology to pathology.","volume":"10","author":"Tang","year":"2023","journal-title":"Adv Sci."},{"key":"B44","first-page":"212","article-title":"Effects of intermittent fasting on experimental autoimune encephalomyelitis in C57BL\/6 Mice.","volume":"15","author":"Razeghi Jahromi","year":"2016","journal-title":"Iran J Aller Asthma Immunol."},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104124","article-title":"Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis.","volume":"82","author":"Fitzgerald","year":"2022","journal-title":"EBioMedicine."},{"key":"B46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.msard.2018.05.002","article-title":"Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.","volume":"23","author":"Fitzgerald","year":"2018","journal-title":"Multiple Scleros Relat Disord."},{"key":"B47","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B48","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B49","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cmet.2018.05.006","article-title":"Intermittent fasting confers protection in CNS autoimmunity by altering the gut microbiota.","volume":"27","author":"Cignarella","year":"2018","journal-title":"Cell Metab."},{"key":"B51","article-title":"Safety and feasibility of various fasting-mimicking diets among people with multiple sclerosis.","volume":"42","author":"Roman","year":"2020","journal-title":"Multiple Scleros Relat Disord."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1087126","article-title":"Feasibility and acceptability of time-restricted eating in a group of adults with multiple sclerosis.","volume":"13","author":"Wingo","year":"2022","journal-title":"Front Neurol."},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143774","article-title":"Targeting the gut to treat multiple sclerosis.","volume":"131","author":"Ghezzi","year":"2021","journal-title":"J Clin Invest."},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity.","volume":"15","author":"Thirion","year":"2023","journal-title":"Genome Med."},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104547","article-title":"The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.","volume":"71","author":"Kumar","year":"2023","journal-title":"Mult Scler Relat Disord."},{"key":"B56","first-page":"573","article-title":"Dietary energy restriction in neurological diseases: what\u2019s new?","volume":"62","author":"Zhang","year":"2023","journal-title":"Eur J Nutr."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103408","article-title":"Intermittent fasting: A promising dietary intervention for autoimmune diseases.","volume":"22","author":"Barati","year":"2023","journal-title":"Autoimmun Rev."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1328426\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T23:18:12Z","timestamp":1705447092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1328426\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":57,"alternative-id":["10.3389\/fnut.2023.1328426"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1328426","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,17]]},"article-number":"1328426"}}